A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for...
Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 9 vom: 15. Sept., Seite 1387-408 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , , , , , , |
Format: | Article |
Langue: | Japanese |
Publié: |
1986
|
Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
Sujets: | Journal Article Anti-Bacterial Agents Cyclopropanes Thienamycins Cilastatin 141A6AMN38 Imipenem 71OTZ9ZE0A |